GABRIELLE BAILEY: Open Payments
NPI 1912595349 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 10 payments from 2 companies in 2025. Trend: 2023 $576 · 2024 $511 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $349 |
| Alkermes, Inc. | 2 | $141 |
Products named: ABILIFY MAINTENA, ARISTADA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across AL — which companies pay providers there.
